Fill and Sign the Chancery Investors Stealth Demand on Biopharma Cant Avoid Form

In str u ctio n: T his i s a m odel l e tte r. A dap t t o f it y our f a cts a n d c ir c u m sta n ces. D ATE N AM EADDRESS L IN EA DDRESS L IN ECIT Y , S T A TE Z IP C O DE Re: vs. C ause N o. ; C hancery C ourt o f C o., D ear : E nclo se d here w ith ple ase fin d an A m en ded C om pla in t w hic h w as file d in th e ab ove re fe re n ced m atte r. U nder th e R ule s o f C iv il P ro ced ure , is re q uir e d to file a re sp onsiv e ple ad in g t o t h e A m en ded C om pla in t w ith in t e n ( 1 0) d ay s o f t h e d ate o f s e rv ic e. I n a d ditio n, b ecau se th e A m en ded C om pla in t w as s ig ned o n t h e , b ut n ot m aile d u ntil t h e , w e a re e n title d t o add th re e (3 ) d ay s to th e a n sw er d ate . A cco rd in g to m y c alc u la tio ns, w e m ust file a re sp onsiv e ple ad in g n o l a te r t h an . I s u ggest t h at w e f ile t h e s a m e M otio n t o D is m is s.W ith r e g ard to a n d , th e P la in tif f is r e q uir e d to o bta in s e rv ic e o f p ro cess a n d a re sp onsiv e p le a d in g w ill b e d ue 3 0 d ay s f ro m t h e d ate o f s e rv ic e.U nle ss I h ear f ro m y ou o th erw is e , I i n te n d t o r e file t h e M otio n t o D is m is s i n r e sp onse t o t h e Am en ded C om pla in t.S hould y ou h av e a n y q uestio ns o r if I c an b e o f f u rth er a ssis ta n ce in a n y w ay , p le ase d o n ot he sita te t o c all. S in cere ly , by: : E ncl.